Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Sangamo Therapeutics Inc (NASDAQ: SGMO) was $0.93 for the day, up 1.22% from the previous closing price of $0.92. In other words, the price has increased by $1.22 from its previous closing price. On the day, 1.88 million shares were traded. SGMO stock price reached its highest trading level at $0.959 during the session, while it also had its lowest trading level at $0.8832.
Ratios:
Our analysis of SGMO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.03 and its Current Ratio is at 1.03. In the meantime, Its Debt-to-Equity ratio is 1.23 whereas as Long-Term Debt/Eq ratio is at 1.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on November 03, 2023, Downgraded its rating to Sector Perform and sets its target price to $2 from $6 previously.
On April 28, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $5 to $1.50.
Wedbush Upgraded its Neutral to Outperform on February 27, 2023, while the target price for the stock was maintained at $16.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 26 ’23 when BIOGEN INC. sold 6,000,000 shares for $0.50 per share. The transaction valued at 3,000,000 led to the insider holds 17,652,466 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMO now has a Market Capitalization of 192854272 and an Enterprise Value of 194164992. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.70 while its Price-to-Book (P/B) ratio in mrq is 8.14. Its current Enterprise Value per Revenue stands at 15.815 whereas that against EBITDA is -1.05.
Stock Price History:
Over the past 52 weeks, SGMO has reached a high of $1.48, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is 17.92%, while the 200-Day Moving Average is calculated to be 44.19%.
Shares Statistics:
SGMO traded an average of 14.52M shares per day over the past three months and 3090690 shares per day over the past ten days. A total of 208.22M shares are outstanding, with a floating share count of 198.84M. Insiders hold about 4.51% of the company’s shares, while institutions hold 41.89% stake in the company. Shares short for SGMO as of 1724976000 were 17964241 with a Short Ratio of 1.24, compared to 1722384000 on 19288733. Therefore, it implies a Short% of Shares Outstanding of 17964241 and a Short% of Float of 8.68.
